trending Market Intelligence /marketintelligence/en/news-insights/trending/husm3qsb_-a_fffvgomqjq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

ImmunoGen board member to step down

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


ImmunoGen board member to step down

ImmunoGen Inc. said its board member Daniel Junius will not stand for re-election at the upcoming annual meeting of the company.

Junius is the former president and CEO of the Waltham, Mass.-based company that develops therapies for cancer.